Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02338102 · ClinicalTrials.gov registry record · NA
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
A NA study of Epistaxis and Nasal Obstruction, sponsored by Lisa Shnayder.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02338102 is a NA study of Epistaxis and Nasal Obstruction that has completed, run by Lisa Shnayder. The registered enrollment target is 36 participants, below the 2,540-participant average among 4 other Epistaxis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02338102, a NA study of Epistaxis and Nasal Obstruction, has completed, sponsored by Lisa Shnayder.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether nasal saline irrigation is beneficial to patients undergoing radiation therapy for oropharyngeal cancer.
Conditions Studied
Interventions
- OTHER Saline mixture
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02338102
The ClinicalTrials.gov registry entry for NCT02338102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,540-participant average among 4 other Epistaxis trials with a reported enrollment target (99% lower). The listed sponsor is Lisa Shnayder, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Epistaxis appearing as the primary indexed condition, and to 1 intervention - of which Saline mixture is the first listed.
NCT02338102 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT02338102 about?
NCT02338102 is a clinical study titled "Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer". The purpose of this study is to learn whether nasal saline irrigation is beneficial to patients undergoing radiation therapy for oropharyngeal cancer.
What is the current status of trial NCT02338102?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-01. Estimated completion is 2015-05.
What conditions does trial NCT02338102 study?
This clinical trial studies the following conditions: Epistaxis, Nasal Obstruction, Rhinitis, Vasomotor.
What interventions are being tested in trial NCT02338102?
The interventions under investigation include: Saline mixture (OTHER).
Who is sponsoring clinical trial NCT02338102?
This trial is sponsored by Lisa Shnayder, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02338102 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epistaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
COMPLETED · NA
-
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
RECRUITING
-
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
ACTIVE NOT RECRUITING · Phase 2
-
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.